Hepatic extraction ratio of 5-fluorouracil in rats
- 1 August 1996
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 52 (4) , 561-568
- https://doi.org/10.1016/0006-2952(96)00307-3
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Preclinical and clinical aspects of biomodulation of 5-fluorouracilCancer Treatment Reviews, 1994
- A phase-III study of recombinant interleukin 2 and 5-fluorouracil chemotherapy in patients with metastatic colorectal cancerBritish Journal of Cancer, 1993
- Novel approaches to selective treatments of human solid tumors: Laboratory and clinical correlationAnnals of Oncology, 1993
- IL-2-dependent generation of natural killer cells from bone marrow: Role of MAC-1−, NK1-1− precursorsCellular Immunology, 1992
- Recombinant interleukin-2 treatment in patients with metastatic colorectal cancer: Effect on natural cytotoxicityCancer Immunology, Immunotherapy, 1992
- Interleukin-2, Cisplatin, and 5-Fluorouracil for Patients with Non-Small Cell Lung and Head/Neck CarcinomasJournal of Immunotherapy, 1991
- Clinical Pharmacology of 5-FluorouracilClinical Pharmacokinetics, 1989
- Efficacy of high-dose oral leucovorin and 5-fluorouracil in advanced colorectal carcinoma. Plasma and tissue pharmacokineticsCancer, 1989
- Fluorouracil: biochemistry and pharmacology.Journal of Clinical Oncology, 1988
- Continuous 5-day regional chemotherapy by 5-fluorouracil in colon carcinoma: Pharmacokinetic evaluationBritish Journal of Cancer, 1985